Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by AesRx, LLC
Sponsor:
Information provided by (Responsible Party):
AesRx, LLC
ClinicalTrials.gov Identifier:
NCT01987908
First received: October 29, 2013
Last updated: November 13, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)